About Doug Samuelson
Doug Samuelson is a chief financial officer at Kairos Pharma.
Doug Samuelson reports to the SEC as an officer of 3 public companies, including Newton Golf Company (NWTG) and Genelux (GNLX).
Doug Samuelson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Doug Samuelson in the role, so the role may have started earlier or lasted longer.
NI
Newton Golf Company, Inc.
Chief Financial Officer
2024 · Public company (NWTG)
GC
Genelux Corp.
Vice President, Finance
2023 · Public company (GNLX)
Key Colleagues at Startups
The people Doug Samuelson works with at each company, as listed on that company's latest Form D.
Kairos Pharma, LTD. · Form D, Jan 28, 2025
HB
Hyun Bae
Independent Director
NB
Neil Bhowmick
Chief Scientific Officer
JY
John Yu
Chairman, Chief Executive Officer, and Director
HK
Hansoo Michael Keyoung
Independent Director
RM
Ramachandran Murali
Vice President of Research and Development
RS
Rahul Singhvi
Independent Director